https://mckuat.mckinsey.com
915b5091-0d7e-44d2-a8c4-cf08267e52fe-test
Skip to main content
Life Sciences
Helping clients outperform and innovate across the life sciences industries
How we help clients
Medtech
Bringing cutting edge capabilities in design, digital and analytics to create innovative products, devices, equipment, software, and solutions that enhance patient value and outcomes.
Generics
Helping companies capture opportunities across the value chain for generics, branded generics, established products and biosimilars, and forging connections among industry stakeholders.
Medical Affairs
Helping clients to transform their medical affairs function into the company’s third strategic pillar alongside R&D and commercial.
Operations
Using our operations expertise to drive performance, increase revenue, and enhance the bottom line.
Research & Development
Helping clients build the R&D capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.
Commercial
Helping clients maximize commercial value by assisting with product launch, marketing, sales, and market access.
How we make a difference
McKinsey Cancer Center
The McKinsey Cancer Center helps life sciences organizations discover, develop, and distribute more effective medicines, deliver better care, and provide broader access to solutions that help patients and their families combat cancer.
Our people
Jake Henry
Senior Partner, Chicago
Leads McKinsey’s global work in medtech, and serves leading medical technology companies as they set strategy, pursue growth opportunities, and...
Chris Llewellyn
Senior Partner, London
Leads our work globally in the life sciences, biopharma, medical products and health technology spaces
Axel Baur
Senior Partner, Hong Kong
Supports healthcare companies to develop global strategies and operating models
Featured capability
POBOS
POBOS provides information on cost, productivity and quality, supply chain performance, and quality performance across more than 35 pharmaceutical and biotech companies. Companies can use the information to understand productivity drivers and their impact and quickly focus efforts on the highest value areas.
Visit our site
Featured insight
Article
Precision medicine in practice: Strategies for rare cancers
May 13, 2021
– The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions,...
but rare cancers face extra barriers to widespread treatment.
Article
Winning against COVID-19: The implications for biopharma
April 15, 2020
– How companies act individually and collectively in the next few weeks and months will shape the outcome of the pandemic and the...
reputation of the biopharma industry for decades to come.
Article
The promise of digital therapeutics
March 31, 2020
– Investments in digital-therapeutics companies in the United States have grown, on average, by 40 percent a year over the past...
seven years. What lies ahead for this fast-moving sector?
Related practice
Healthcare Systems & Services
Connect with our Life Sciences Practice
Contact